Letters

Robert Finn (The Scientist, June 10, 1996, page 15) recently considered the increasing opportunities for academic life scientists to serve as consultants for industry. Finn's article mentioned rewards and drawbacks of such consulting for "biologists," but did not consider the concerns of a sizable subset of consultants, namely those life scientists asked to serve as experts in litigation. Scientists such as toxicologists, who can often command a hefty fee for their expertise, must exert extrem

Written byRonald Hood
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Robert Finn (The Scientist, June 10, 1996, page 15) recently considered the increasing opportunities for academic life scientists to serve as consultants for industry. Finn's article mentioned rewards and drawbacks of such consulting for "biologists," but did not consider the concerns of a sizable subset of consultants, namely those life scientists asked to serve as experts in litigation.

Scientists such as toxicologists, who can often command a hefty fee for their expertise, must exert extreme caution to avoid the temptation to provide biased testimony or to go beyond the supportable science. Further, if a case proceeds to deposition or courtroom testimony, a naïve "expert" may be devastated by the attack of an aggressive opposing attorney, whose goal is to win the case and whose methods are likely to include attempts to make the witness look "foolish, unprepared, or intemperate" (R.D. Hood, Reproductive Toxicology, 8:269-73, 1994). Nevertheless, only when well-qualified scientists ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies